Cytokeratin 19 antibody (C-Term)
Quick Overview for Cytokeratin 19 antibody (C-Term) (ABIN870575)
Target
See all Cytokeratin 19 (KRT19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 386-399, C-Term
-
Purpose
- Anti-Cytokeratin 19
-
Specificity
- Cytokeratin 19
-
Immunogen
- Peptide derived from C-terminal region of human cytokeratin 19. Antibody recognizes the epitope between Gly386 - Val399.
-
Isotype
- IgG
-
-
-
-
Application Notes
- 1:100 - 200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- +2 °C to +8 °C
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Alternative Name
- Cytokeratin 19
-
Background
- Cytokeratin 19 expression is associated with a wide variety of epithelium and epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver and breast.
-
UniProt
- P08727
Target
-